Kim D - Search Results

1

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Dibba P, et al. Among authors: kim d. Diseases. 2018 Sep 19;6(3):83. doi: 10.3390/diseases6030083. Diseases. 2018. PMID: 30235807 Free PMC article. Review.

2

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

Perumpail BJ, Cholankeril R, Yoo ER, Kim D, Ahmed A. Perumpail BJ, et al. Among authors: kim d. Diseases. 2017 Oct 22;5(4):23. doi: 10.3390/diseases5040023. Diseases. 2017. PMID: 29065499 Free PMC article. Review.

3

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

Yim JY, Kim J, Kim D, Ahmed A. Yim JY, et al. Among authors: kim d, kim j. Liver Int. 2018 Nov;38(11):2051-2059. doi: 10.1111/liv.13735. Epub 2018 Mar 31. Liver Int. 2018. PMID: 29517842

4

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation.

Li AA, Dibba P, Cholankeril G, Kim D, Ahmed A. Li AA, et al. Among authors: kim d. Diseases. 2018 May 19;6(2):40. doi: 10.3390/diseases6020040. Diseases. 2018. PMID: 29783726 Free PMC article.

5

Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.

Kim D, Li AA, Ahmed A. Kim D, et al. Liver Int. 2018 Oct;38(10):1839-1848. doi: 10.1111/liv.13886. Epub 2018 Jun 12. Liver Int. 2018. PMID: 29797393

6

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. Dibba P, et al. Among authors: kim d. Medicines (Basel). 2018 May 28;5(2):47. doi: 10.3390/medicines5020047. Medicines (Basel). 2018. PMID: 29843404 Free PMC article. Review.

7

The Role of Cannabinoids in the Setting of Cirrhosis.

Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. Dibba P, et al. Among authors: kim d. Medicines (Basel). 2018 Jun 9;5(2):52. doi: 10.3390/medicines5020052. Medicines (Basel). 2018. PMID: 29890719 Free PMC article. Review.

8

Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.

Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, Glenn JS, Harrison SA, Younossi ZM, Ahmed A. Kim D, et al. Among authors: kim w. Hepatology. 2019 Mar;69(3):1064-1074. doi: 10.1002/hep.30161. Epub 2019 Feb 11. Hepatology. 2019. PMID: 30014489 Free PMC article.

9

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.

Kang SJ, Kim HJ, Kim D, Ahmed A. Kang SJ, et al. Among authors: kim hj, kim d. PLoS One. 2018 Aug 15;13(8):e0202325. doi: 10.1371/journal.pone.0202325. eCollection 2018. PLoS One. 2018. PMID: 30110395 Free PMC article.

10

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016.

Li AA, Kim D, Kim W, Dibba P, Wong K, Cholankeril G, Jacobson IM, Younossi ZM, Ahmed A. Li AA, et al. Among authors: kim w, kim d. J Viral Hepat. 2018 Dec;25(12):1608-1616. doi: 10.1111/jvh.12981. Epub 2018 Sep 11. J Viral Hepat. 2018. PMID: 30112849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,577 results

Search Page

Filters